Brawn Biotech Ltd

₹ 21.1 -4.31%

31 Oct - close price

About

Incorporated in 1985, Brawn Biotech Ltd is in the business of trading pharmaceutical products^[1]

Key Points

Business Overview:^[1]
BBL is a fully integrated healthcare company that deals in pharmaceutical products, covering segments:
a) Antibacterial
b) Cardiovascular
c) Antidiabetics
d) Analgesics
e) Gastrointestinal
f) Antifungals
g) Skin Care
h) Antipsychotics,
i) Anti-asthmatics
j) Antacids
k) Antimalarial
l) Nutritional

Website BSE

Market Cap ₹ 6.33 Cr.
Current Price ₹ 21.1
High / Low ₹ 26.0 / 15.5
Stock P/E 48.7
Book Value ₹
Dividend Yield 0.00 %
ROCE %
ROE %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2022	Mar 2023	Jun 2023
	0.12	0.12	0.12
	0.09	0.08	0.16
Operating Profit	0.03	0.04	-0.04
OPM %	25.00%	33.33%	-33.33%
	0.00	0.23	0.00
Interest	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00
Profit before tax	0.03	0.27	-0.04
Tax %	0.00%	14.81%	0.00%
	0.02	0.23	-0.04
EPS in Rs	0.07	0.77	-0.13
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023
	0.48
	0.49
Operating Profit	-0.01
OPM %	-2.08%
	0.24
Interest	0.00
Depreciation	0.01
Profit before tax	0.22
Tax %	18.18%
	0.19
EPS in Rs	0.63
Dividend Payout %	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Stock Price CAGR
10 Years:	-5%
5 Years:	0%
3 Years:	2%
1 Year:	8%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023
Equity Capital
Reserves


Total Liabilities

CWIP
Investments

Total Assets

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023



Net Cash Flow

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
	53.72%	53.72%	53.72%	53.72%	53.72%	53.64%	53.64%	53.64%	53.64%	53.66%	53.66%	53.66%
	0.59%	0.59%	0.59%	0.59%	0.59%	0.35%	0.35%	0.35%	0.35%	0.35%	0.35%	0.35%
	45.69%	45.69%	45.69%	45.69%	45.69%	46.02%	46.02%	46.02%	46.02%	46.01%	46.00%	45.99%
No. of Shareholders	6,275	6,222	6,246	6,194	6,139	4,160	4,090	4,157	4,060	4,024	3,975	3,958

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
	53.68%	53.39%	53.70%	53.71%	53.71%	53.71%	53.72%	53.64%	53.66%	53.66%
	0.59%	0.59%	0.59%	0.59%	0.59%	0.59%	0.59%	0.35%	0.35%	0.35%
	45.73%	46.02%	45.70%	45.69%	45.69%	45.69%	45.69%	46.02%	46.01%	45.99%
No. of Shareholders	6,237	6,219	6,150	6,074	5,991	6,288	6,222	4,160	4,024	3,958

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Brawn Biotech Ltd

Brawn Biotech Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports